Proposed Symbol: GELS
Company Name: Gelteq Ltd
Exchange: NASDAQ Capital
Share Price: $5.00
Employees: 8 (as of 03/31/2024)
Status: Filed
Shares Offered: 1,300,000
Offer Amount: $7,475,000
Shares Over-Allotted: 195,000
Company Address:
Level 4, 100 Albert Road
South Melbourne, VIC 3205
Company Phone: +61 3 9087 3990
Company Website: www.gelteq.com
CEO: Nathan J. Givoni
Fiscal Year End: 12/31
Lockup Period: 180 days
Financial Highlights
- Revenue: $72,674.00
- Net Income: -$1,574,041.00
- Total Assets: $13,844,624.00
- Total Liabilities: $3,247,731.00
- Stockholders’ Equity: $10,714,307.00
- Total Offering Expense: $450,000.00
- Shares Outstanding: 9,438,075
Company Filings
Company Filings
| Company Name | Form Type | Date Received | View |
|---|---|---|---|
| Gelteq Ltd | F-1 | 07/15/2024 | Link |
| Gelteq Ltd | F-1/A | 09/12/2024 | Link |
| Gelteq Ltd | F-1/A | 09/25/2024 | Link |
Key Experts
- Auditor: M&K CPAS, PLLC
- Company Counsel: Ellenoff Grossman & Schole LLP
- Lead Underwriters: EF Hutton LLC, The Benchmark Company, LLC
- Transfer Agent: Bank of New York Mellon, Not Specified
- Underwriter Counsel: Sichenzia Ross Ference Carmel LLP
Company Description
Gelteq Ltd is a clinical and science-based company specializing in the development and commercialization of white-label gel-based delivery solutions for various applications, including prescription drugs, nutraceuticals, and pet care products. The company focuses on producing edible gels and offers multiple products across five core verticals: pets, sports, pharmaceuticals, over-the-counter (OTC) products, and nutraceuticals.
Gelteq aims to out-license its innovative technology to partners, allowing them to create and sell new products in established markets while continuing to manufacture its existing offerings under a white-label model. The company has seen initial orders from two clients in the nutraceutical sector and four products in the sports vertical.
Despite facing challenges with some clients’ cash flow, Gelteq is implementing strategies to ensure future orders are fulfilled efficiently. The company is also focused on expanding its intellectual property portfolio, including several pending and granted patents to protect its unique gel delivery technology.
Intellectual Property and Future Plans
Gelteq is actively pursuing various patents to safeguard its innovative gel delivery systems and related products. The company aims to continue enhancing its production capacity and expand its market reach, leveraging its scientific expertise and strategic partnerships to change the landscape of health delivery for both humans and animals.
The company’s commitment to innovation and efficiency positions it well for future growth and success in the health and wellness sectors.